<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Exp Otorhinolaryngol</journal-id><journal-id journal-id-type="iso-abbrev">Clin Exp Otorhinolaryngol</journal-id><journal-id journal-id-type="publisher-id">CEO</journal-id><journal-title-group><journal-title>Clinical and Experimental Otorhinolaryngology</journal-title></journal-title-group><issn pub-type="ppub">1976-8710</issn><issn pub-type="epub">2005-0720</issn><publisher><publisher-name>Korean Society of Otorhinolaryngology-Head and Neck Surgery</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27459198</article-id><article-id pub-id-type="pmc">5426394</article-id><article-id pub-id-type="doi">10.21053/ceo.2016.00563</article-id><article-id pub-id-type="publisher-id">ceo-2016-00563</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Premedication Methods in Nasal Endoscopy: A Prospective, Randomized, Double-Blind Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Şahin</surname><given-names>Mehmet İlhan</given-names></name><xref ref-type="corresp" rid="c1-ceo-2016-00563"></xref><xref ref-type="aff" rid="af1-ceo-2016-00563"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kökoğlu</surname><given-names>Kerem</given-names></name><xref ref-type="aff" rid="af1-ceo-2016-00563"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Güleç</surname><given-names>Şafak</given-names></name><xref ref-type="aff" rid="af2-ceo-2016-00563"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ketenci</surname><given-names>İbrahim</given-names></name><xref ref-type="aff" rid="af1-ceo-2016-00563"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ünlü</surname><given-names>Yaşar</given-names></name><xref ref-type="aff" rid="af1-ceo-2016-00563"><sup>1</sup></xref></contrib><aff id="af1-ceo-2016-00563"><label>1</label>Department of Otolaryngology, Erciyes University Medical School, Kayseri, <country>Turkey</country></aff><aff id="af2-ceo-2016-00563"><label>2</label>Department of Otolaryngology, Akdağmadeni State Hospital, Yozgat, <country>Turkey</country></aff></contrib-group><author-notes><corresp id="c1-ceo-2016-00563">Corresponding author: Mehmet İlhan Şahin, Department of Otolaryngology, Erciyes University Medical School, Talas Yolu, Kayseri 38039, Turkey Tel: +90-352-207-6666, Fax: +90-352-437-5273 E-mail: <email>misahin@erciyes.edu.tr</email></corresp></author-notes><pub-date pub-type="ppub"><month>6</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>27</day><month>7</month><year>2016</year></pub-date><volume>10</volume><issue>2</issue><fpage>158</fpage><lpage>163</lpage><history><date date-type="received"><day>27</day><month>4</month><year>2016</year></date><date date-type="rev-recd"><day>7</day><month>6</month><year>2016</year></date><date date-type="accepted"><day>17</day><month>6</month><year>2016</year></date></history><permissions><copyright-statement>Copyright © 2017 by Korean Society of Otorhinolaryngology-Head and Neck Surgery</copyright-statement><copyright-year>2017</copyright-year><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0">http://creativecommons.org/licenses/by-nc/4.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title><offsets xml_i="3914" xml_f="3924" txt_i="11" txt_f="21">Objectives</offsets></title><p><offsets xml_i="3935" xml_f="4024" txt_i="22" txt_f="111">To identify the optimal pharmacological method of preparing patients for nasal endoscopy.</offsets></p></sec><sec><title><offsets xml_i="4046" xml_f="4053" txt_i="113" txt_f="120">Methods</offsets></title><p><offsets xml_i="4064" xml_f="4923" txt_i="121" txt_f="980"> Twenty healthy volunteers were enrolled in this prospective, randomized, double-blind study. Four types of medications were applied in their nostrils with binary combinations of spray bottles on four different days in a random order: placebo (normal saline [NS]+NS), decongestant (NS+oxymetazoline), anesthetic (NS+lidocaine), and decongestant plus anesthetic (oxymetazoline+lidocaine). Rigid nasal endoscopy was performed 10 minutes after spray application. The volunteers evaluated the discomfort caused by each spray application, and nasal pain scores due to the passage of the endoscope. The physicians quantified nasal decongestion using a visual analogue scale. Endoscopy duration as well as pulse and mean blood pressure (MBP) before spray application, 10 minutes after the application, and immediately after endoscopic examination were also recorded.</offsets></p></sec><sec><title><offsets xml_i="4945" xml_f="4952" txt_i="982" txt_f="989">Results</offsets></title><p><offsets xml_i="4963" xml_f="5062" txt_i="990" txt_f="1089"> The discomfort caused by lidocaine was significantly higher than that caused by the other sprays (</offsets><italic><offsets xml_i="5070" xml_f="5071" txt_i="1089" txt_f="1090">P</offsets></italic><offsets xml_i="5080" xml_f="5177" txt_i="1090" txt_f="1184">&lt;0.001). The lowest pain score related to endoscopy was obtained for oxymetazoline+lidocaine (</offsets><italic><offsets xml_i="5185" xml_f="5186" txt_i="1184" txt_f="1185">P</offsets></italic><offsets xml_i="5195" xml_f="5267" txt_i="1185" txt_f="1254">&lt;0.001). Nasal decongestion was best achieved with NS+oxymetazoline (</offsets><italic><offsets xml_i="5275" xml_f="5276" txt_i="1254" txt_f="1255">P</offsets></italic><offsets xml_i="5285" xml_f="5363" txt_i="1255" txt_f="1330">&lt;0.001). Endoscopy duration was the shortest for oxymetazoline+ lidocaine (</offsets><italic><offsets xml_i="5371" xml_f="5372" txt_i="1330" txt_f="1331">P</offsets></italic><offsets xml_i="5381" xml_f="5487" txt_i="1331" txt_f="1434">&lt;0.05). Statistically significant MBP changes were only seen with the application of NS+oxymetazoline (</offsets><italic><offsets xml_i="5495" xml_f="5496" txt_i="1434" txt_f="1435">P</offsets></italic><offsets xml_i="5505" xml_f="5586" txt_i="1435" txt_f="1513">&lt;0.05). However, neither MBP nor pulse rate change was significant clinically.</offsets></p></sec><sec><title><offsets xml_i="5608" xml_f="5618" txt_i="1515" txt_f="1525">Conclusion</offsets></title><p><offsets xml_i="5629" xml_f="5780" txt_i="1526" txt_f="1677"> Application of decongestant and anesthetic sprays together seems to be the best method of pharmacological preparation of patients for nasal endoscopy.</offsets></p></sec></abstract><kwd-group><kwd>Anesthetics</kwd><kwd>Nasal Decongestants</kwd><kwd>Lidocaine</kwd><kwd>Oxymetazoline</kwd><kwd>Endoscopy</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title><offsets xml_i="5998" xml_f="6010" txt_i="1686" txt_f="1698">INTRODUCTION</offsets></title><p><offsets xml_i="6021" xml_f="6118" txt_i="1699" txt_f="1796">Nasal endoscopy (NE) is a widespread and valuable examination method in otolaryngology practice [</offsets><xref rid="b1-ceo-2016-00563" ref-type="bibr"><offsets xml_i="6164" xml_f="6165" txt_i="1796" txt_f="1797">1</offsets></xref><offsets xml_i="6172" xml_f="6461" txt_i="1797" txt_f="2086">]. NE allows the visualization of the posterior and superior parts of the nasal airway, which cannot be seen by other means, e.g., anterior rhinoscopy. NE is usually accomplished with a rigid endoscope, but a flexible endoscope is preferred in patients with severe nasal septal deviation [</offsets><xref rid="b2-ceo-2016-00563" ref-type="bibr"><offsets xml_i="6507" xml_f="6508" txt_i="2086" txt_f="2087">2</offsets></xref><offsets xml_i="6515" xml_f="6581" txt_i="2087" txt_f="2153">]. For the patients, NE is a painful and uncomfortable procedure [</offsets><xref rid="b3-ceo-2016-00563" ref-type="bibr"><offsets xml_i="6627" xml_f="6628" txt_i="2153" txt_f="2154">3</offsets></xref><offsets xml_i="6635" xml_f="6924" txt_i="2154" txt_f="2443">]; for the physicians, the disadvantages are prolonged procedure duration and limited view of nasal passages due to hypertrophic and swollen turbinates. In addition, some physiological changes such as acceleration of pulse rate and increase of blood pressure have been associated with NE [</offsets><xref rid="b4-ceo-2016-00563" ref-type="bibr"><offsets xml_i="6970" xml_f="6971" txt_i="2443" txt_f="2444">4</offsets></xref><offsets xml_i="6978" xml_f="6980" txt_i="2444" txt_f="2446">].</offsets></p><p><offsets xml_i="6987" xml_f="7346" txt_i="2447" txt_f="2806">As a preparation for NE, a local anesthetic and/or a decongestant are usually applied to nostrils in order to alleviate the nasal pain, to widen the field of view, and to shorten the duration of the examination. However, the benefits of local anesthetics are controversial, partly because they cause discomfort to patients because of the bad taste and smell [</offsets><xref rid="b5-ceo-2016-00563" ref-type="bibr"><offsets xml_i="7392" xml_f="7393" txt_i="2806" txt_f="2807">5</offsets></xref><offsets xml_i="7400" xml_f="7401" txt_i="2807" txt_f="2808">,</offsets><xref rid="b6-ceo-2016-00563" ref-type="bibr"><offsets xml_i="7447" xml_f="7448" txt_i="2808" txt_f="2809">6</offsets></xref><offsets xml_i="7455" xml_f="7571" txt_i="2809" txt_f="2925">]. Furthermore, there is always a suspicion that local decongestants may cause hypertension and reflex bradycardia [</offsets><xref rid="b7-ceo-2016-00563" ref-type="bibr"><offsets xml_i="7617" xml_f="7618" txt_i="2925" txt_f="2926">7</offsets></xref><offsets xml_i="7625" xml_f="7722" txt_i="2926" txt_f="3023">]. Some authors recommend no medication before NE on the strength of placebo-controlled studies [</offsets><xref rid="b8-ceo-2016-00563" ref-type="bibr"><offsets xml_i="7768" xml_f="7769" txt_i="3023" txt_f="3024">8</offsets></xref><offsets xml_i="7776" xml_f="7777" txt_i="3024" txt_f="3025">-</offsets><xref rid="b11-ceo-2016-00563" ref-type="bibr"><offsets xml_i="7824" xml_f="7826" txt_i="3025" txt_f="3027">11</offsets></xref><offsets xml_i="7833" xml_f="7937" txt_i="3027" txt_f="3131">]. Other authors recommend only decongestant or decongestant–local anesthetic combination applications [</offsets><xref rid="b12-ceo-2016-00563" ref-type="bibr"><offsets xml_i="7984" xml_f="7986" txt_i="3131" txt_f="3133">12</offsets></xref><offsets xml_i="7993" xml_f="7994" txt_i="3133" txt_f="3134">-</offsets><xref rid="b14-ceo-2016-00563" ref-type="bibr"><offsets xml_i="8041" xml_f="8043" txt_i="3134" txt_f="3136">14</offsets></xref><offsets xml_i="8050" xml_f="8145" txt_i="3136" txt_f="3231">]. Nevertheless, there is no consensus about the best method of preparing the patients for NE [</offsets><xref rid="b1-ceo-2016-00563" ref-type="bibr"><offsets xml_i="8191" xml_f="8192" txt_i="3231" txt_f="3232">1</offsets></xref><offsets xml_i="8199" xml_f="8200" txt_i="3232" txt_f="3233">,</offsets><xref rid="b3-ceo-2016-00563" ref-type="bibr"><offsets xml_i="8246" xml_f="8247" txt_i="3233" txt_f="3234">3</offsets></xref><offsets xml_i="8254" xml_f="8255" txt_i="3234" txt_f="3235">,</offsets><xref rid="b10-ceo-2016-00563" ref-type="bibr"><offsets xml_i="8302" xml_f="8304" txt_i="3235" txt_f="3237">10</offsets></xref><offsets xml_i="8311" xml_f="8312" txt_i="3237" txt_f="3238">,</offsets><xref rid="b15-ceo-2016-00563" ref-type="bibr"><offsets xml_i="8359" xml_f="8361" txt_i="3238" txt_f="3240">15</offsets></xref><offsets xml_i="8368" xml_f="8369" txt_i="3240" txt_f="3241">,</offsets><xref rid="b16-ceo-2016-00563" ref-type="bibr"><offsets xml_i="8416" xml_f="8418" txt_i="3241" txt_f="3243">16</offsets></xref><offsets xml_i="8425" xml_f="8427" txt_i="3243" txt_f="3245">].</offsets></p><p><offsets xml_i="8434" xml_f="8637" txt_i="3246" txt_f="3449">In this study, we aimed to identify the optimal pharmacological method of preparing the patients for NE while considering both the clinicians’ needs and the patients’ comfort and physiological stability.</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="8688" xml_f="8709" txt_i="3451" txt_f="3472">MATERIALS AND METHODS</offsets></title><p><offsets xml_i="8720" xml_f="9022" txt_i="3473" txt_f="3775">This prospective, randomized, double-blind study was approved by the local ethics committee. After obtaining informed consents, 20 healthy volunteers were enrolled. Exclusion criteria were asthma, cardiovascular disease, rhinitis, severe septal deviation, and a history of nasal endoscopic examination.</offsets></p><p><offsets xml_i="9029" xml_f="9428" txt_i="3776" txt_f="4175">Four spray bottles of similar external appearance were prepared and numbered; two of the bottles contained normal saline (NS; 0.9% sodium chloride), one contained Iliadin (0.05% oxymetazoline; Merck, Darmstadt, Germany), and one contained Xylocaine (10% lidocaine; AstraZeneca, Södertälje, Sweden). The nurse who prepared the bottles was the only person who was aware of the contents of the bottles.</offsets></p><p><offsets xml_i="9435" xml_f="9931" txt_i="4176" txt_f="4672">Four binary combinations of sprays were applied in each subject’s nostrils in a random order on four different days. In each day, two puffs (one puff per bottle; 0.1 mg oxymetazoline for Iliadin, 20 mg lidocaine for Xylocaine) were applied to both nostrils by the same clinical nurse. All four combinations were applied to each subject to reduce the bias of subjective evaluation and eliminate individual differences. The application and evaluation processes were identical for each combination (</offsets><xref rid="f1-ceo-2016-00563" ref-type="fig"><offsets xml_i="9976" xml_f="9982" txt_i="4672" txt_f="4678">Fig. 1</offsets></xref><offsets xml_i="9989" xml_f="9991" txt_i="4678" txt_f="4680">).</offsets></p><sec><title><offsets xml_i="10007" xml_f="10025" txt_i="4681" txt_f="4699">Spray combinations</offsets></title><p><offsets xml_i="10036" xml_f="10224" txt_i="4700" txt_f="4888">The four binary combinations of sprays were as follows: placebo (NS+NS), decongestant (NS+oxymetazoline), anesthetic (NS+lidocaine), decongestant plus anesthetic (oxymetazoline+lidocaine).</offsets></p></sec><sec><title><offsets xml_i="10246" xml_f="10261" txt_i="4890" txt_f="4905">Nasal endoscopy</offsets></title><p><offsets xml_i="10272" xml_f="10701" txt_i="4906" txt_f="5331">All endoscopies were performed 10 minutes after medications by the same experienced physician who was blinded to the administered drugs using a 4.0-mm, 0-degree rigid endoscope (Karl STORZ GmbH &amp; Co. KG, Tuttlingen, Germany). In each endoscopy, choana, middle meatus, sphenoethmoidal recess, and superior concha were observed in both nasal passages. The nurse recorded the durations of the endoscopic examinations as seconds.</offsets></p></sec><sec><title><offsets xml_i="10723" xml_f="10743" txt_i="5333" txt_f="5353">Clinical evaluations</offsets></title><sec><title><offsets xml_i="10763" xml_f="10805" txt_i="5354" txt_f="5396">Evaluation of discomfort due to the sprays</offsets></title><p><offsets xml_i="10816" xml_f="11065" txt_i="5397" txt_f="5646">Shortly after spraying each bottle, subjects were asked to indicate their degree of discomfort on a visual analogue scale (VAS) (1: no discomfort, 10: utmost discomfort). For each combination, two independent scores were obtained from each subject (</offsets><xref rid="f2-ceo-2016-00563" ref-type="fig"><offsets xml_i="11110" xml_f="11116" txt_i="5646" txt_f="5652">Fig. 2</offsets></xref><offsets xml_i="11123" xml_f="11125" txt_i="5652" txt_f="5654">).</offsets></p></sec><sec><title><offsets xml_i="11147" xml_f="11207" txt_i="5656" txt_f="5716">Evaluation of nasal pain due to the passage of the endoscope</offsets></title><p><offsets xml_i="11218" xml_f="11340" txt_i="5717" txt_f="5839">Shortly after endoscopy, subjects were asked to indicate their degree of pain on a VAS (1: no pain, 10: unbearable pain) (</offsets><xref rid="f2-ceo-2016-00563" ref-type="fig"><offsets xml_i="11385" xml_f="11391" txt_i="5839" txt_f="5845">Fig. 2</offsets></xref><offsets xml_i="11398" xml_f="11400" txt_i="5845" txt_f="5847">).</offsets></p></sec><sec><title><offsets xml_i="11422" xml_f="11464" txt_i="5849" txt_f="5891">Evaluation of decongestion (field of view)</offsets></title><p><offsets xml_i="11475" xml_f="11648" txt_i="5892" txt_f="6065">Shortly after endoscopy, the endoscopist was asked to indicate the degree of nasal decongestion on a VAS (1: impossible to pass the endoscope, 10: excellent field of view) (</offsets><xref rid="f2-ceo-2016-00563" ref-type="fig"><offsets xml_i="11693" xml_f="11699" txt_i="6065" txt_f="6071">Fig. 2</offsets></xref><offsets xml_i="11706" xml_f="11708" txt_i="6071" txt_f="6073">).</offsets></p></sec><sec><title><offsets xml_i="11730" xml_f="11769" txt_i="6075" txt_f="6114">Measurement of blood pressure and pulse</offsets></title><p><offsets xml_i="11780" xml_f="12354" txt_i="6115" txt_f="6689">The blood pressure and pulse were measured thrice at each application: just before spray application (10 minutes after a rest); 10 minutes after spray application (just before the endoscopy); and immediately after the endoscopy. The same nurse did all the measurements. Blood pressure was measured with the same calibrated manometer and from the same arm of each subject. Mean blood pressures (MBP) in mmHg and change between the measurements for each application were recorded. Pulse rate was detected by palpating the radial artery, and recorded as beats per minute (BPM).</offsets></p></sec></sec><sec><title><offsets xml_i="12382" xml_f="12402" txt_i="6692" txt_f="6712">Statistical analysis</offsets></title><p><offsets xml_i="12413" xml_f="12477" txt_i="6713" txt_f="6777">For statistical analyses, SigmaStat 3.5 (Systat Software, Inc.; </offsets><ext-link ext-link-type="uri" xlink:href="http://www.sigmaplot.co.uk/"><offsets xml_i="12548" xml_f="12575" txt_i="6777" txt_f="6804">http://www.sigmaplot.co.uk/</offsets></ext-link><offsets xml_i="12586" xml_f="13130" txt_i="6804" txt_f="7348">) software was used. A Shapiro-Wilk test was used to test the normality of data distribution. Normally distributed data are presented as means±standard deviation (SD). An analysis of variance test was used for repeated measures. Pairwise comparisons were performed by using the post-hoc parametric Student-Newman-Keuls method. The data, which was not normally distributed, are presented as medians (range), and a Friedman test was used for their analysis. Pairwise comparisons were performed by the nonparametric Student-Newman-Keuls method. A </offsets><italic><offsets xml_i="13138" xml_f="13139" txt_i="7348" txt_f="7349">P</offsets></italic><offsets xml_i="13148" xml_f="13211" txt_i="7349" txt_f="7412">-value less than 0.05 was considered statistically significant.</offsets></p></sec></sec><sec sec-type="results"><title><offsets xml_i="13258" xml_f="13265" txt_i="7415" txt_f="7422">RESULTS</offsets></title><p><offsets xml_i="13276" xml_f="13380" txt_i="7423" txt_f="7527">Twenty volunteers (12 men, 8 women) aged 27±7 years (range, 19 to 50 years) were enrolled in this study.</offsets></p><p><offsets xml_i="13387" xml_f="13485" txt_i="7528" txt_f="7626">The discomfort caused by lidocaine was significantly higher than that caused by the other sprays (</offsets><italic><offsets xml_i="13493" xml_f="13494" txt_i="7626" txt_f="7627">P</offsets></italic><offsets xml_i="13503" xml_f="13585" txt_i="7627" txt_f="7706">&lt;0.001). There were no differences in discomfort between oxymetazoline and NS (</offsets><italic><offsets xml_i="13593" xml_f="13594" txt_i="7706" txt_f="7707">P</offsets></italic><offsets xml_i="13603" xml_f="13614" txt_i="7707" txt_f="7715">&gt;0.05) (</offsets><xref rid="f3-ceo-2016-00563" ref-type="fig"><offsets xml_i="13659" xml_f="13665" txt_i="7715" txt_f="7721">Fig. 3</offsets></xref><offsets xml_i="13672" xml_f="13674" txt_i="7721" txt_f="7723">).</offsets></p><p><offsets xml_i="13681" xml_f="13792" txt_i="7724" txt_f="7835">Nasal pain scores due to the passage of the endoscope were significantly different between spray combinations (</offsets><italic><offsets xml_i="13800" xml_f="13801" txt_i="7835" txt_f="7836">P</offsets></italic><offsets xml_i="13810" xml_f="13886" txt_i="7836" txt_f="7909">&lt;0.001). The lowest pain score was obtained for oxymetazoline+lidocaine (</offsets><italic><offsets xml_i="13894" xml_f="13895" txt_i="7909" txt_f="7910">P</offsets></italic><offsets xml_i="13904" xml_f="13915" txt_i="7910" txt_f="7918">&lt;0.05) (</offsets><xref rid="f4-ceo-2016-00563" ref-type="fig"><offsets xml_i="13960" xml_f="13966" txt_i="7918" txt_f="7924">Fig. 4</offsets></xref><offsets xml_i="13973" xml_f="14042" txt_i="7924" txt_f="7993">). There were no differences in pain between NS+lidocaine and NS+NS (</offsets><italic><offsets xml_i="14050" xml_f="14051" txt_i="7993" txt_f="7994">P</offsets></italic><offsets xml_i="14060" xml_f="14070" txt_i="7994" txt_f="8001">&gt;0.05).</offsets></p><p><offsets xml_i="14077" xml_f="14160" txt_i="8002" txt_f="8085">Nasal decongestion scores were significantly different between spray combinations (</offsets><italic><offsets xml_i="14168" xml_f="14169" txt_i="8085" txt_f="8086">P</offsets></italic><offsets xml_i="14178" xml_f="14250" txt_i="8086" txt_f="8155">&lt;0.001). Nasal decongestion was best achieved with NS+oxymetazoline (</offsets><italic><offsets xml_i="14258" xml_f="14259" txt_i="8155" txt_f="8156">P</offsets></italic><offsets xml_i="14268" xml_f="14323" txt_i="8156" txt_f="8208">&lt;0.001), whereas NS+lidocaine had the least effect (</offsets><xref rid="f4-ceo-2016-00563" ref-type="fig"><offsets xml_i="14368" xml_f="14374" txt_i="8208" txt_f="8214">Fig. 4</offsets></xref><offsets xml_i="14381" xml_f="14491" txt_i="8214" txt_f="8324">). Nasal decongestion scores were significantly higher for NS+oxymetazoline than for oxymetazoline+lidocaine (</offsets><italic><offsets xml_i="14499" xml_f="14500" txt_i="8324" txt_f="8325">P</offsets></italic><offsets xml_i="14509" xml_f="14520" txt_i="8325" txt_f="8333">&lt;0.05) (</offsets><xref rid="f4-ceo-2016-00563" ref-type="fig"><offsets xml_i="14565" xml_f="14571" txt_i="8333" txt_f="8339">Fig. 4</offsets></xref><offsets xml_i="14578" xml_f="14580" txt_i="8339" txt_f="8341">).</offsets></p><p><offsets xml_i="14587" xml_f="14705" txt_i="8342" txt_f="8460">Duration of endoscopy was significantly shorter for oxymetazoline+lidocaine compared to the other spray combinations (</offsets><italic><offsets xml_i="14713" xml_f="14714" txt_i="8460" txt_f="8461">P</offsets></italic><offsets xml_i="14723" xml_f="14796" txt_i="8461" txt_f="8531">&lt;0.05), and there were no differences between the other combinations (</offsets><italic><offsets xml_i="14804" xml_f="14805" txt_i="8531" txt_f="8532">P</offsets></italic><offsets xml_i="14814" xml_f="14825" txt_i="8532" txt_f="8540">&gt;0.05) (</offsets><xref rid="f5-ceo-2016-00563" ref-type="fig"><offsets xml_i="14870" xml_f="14876" txt_i="8540" txt_f="8546">Fig. 5</offsets></xref><offsets xml_i="14883" xml_f="14885" txt_i="8546" txt_f="8548">).</offsets></p><p><offsets xml_i="14892" xml_f="14986" txt_i="8549" txt_f="8643">MBP values were increased significantly by 4.05±3.31 mmHg after NS+oxymetazoline application (</offsets><italic><offsets xml_i="14994" xml_f="14995" txt_i="8643" txt_f="8644">P</offsets></italic><offsets xml_i="15004" xml_f="15015" txt_i="8644" txt_f="8652">&lt;0.05) (</offsets><xref rid="f6-ceo-2016-00563" ref-type="fig"><offsets xml_i="15060" xml_f="15066" txt_i="8652" txt_f="8658">Fig. 6</offsets></xref><offsets xml_i="15073" xml_f="15272" txt_i="8658" txt_f="8857">). However, neither this change nor the changes of MBP with the other combinations were clinically meaningful. There were no significant changes in pulse rates, neither statistically nor clinically (</offsets><italic><offsets xml_i="15280" xml_f="15281" txt_i="8857" txt_f="8858">P</offsets></italic><offsets xml_i="15290" xml_f="15301" txt_i="8858" txt_f="8866">&gt;0.05) (</offsets><xref rid="f7-ceo-2016-00563" ref-type="fig"><offsets xml_i="15346" xml_f="15352" txt_i="8866" txt_f="8872">Fig. 7</offsets></xref><offsets xml_i="15359" xml_f="15522" txt_i="8872" txt_f="9035">). After endoscopy, MBP values were decreased significantly by 7.05±6.41 mmHg, and pulse rates were decreased significantly by 8.65±7.82 BPM for NS+oxymetazoline (</offsets><italic><offsets xml_i="15530" xml_f="15531" txt_i="9035" txt_f="9036">P</offsets></italic><offsets xml_i="15540" xml_f="15633" txt_i="9036" txt_f="9126">&lt;0.001). There were no differences in MBP or pulse rate for the other spray combinations (</offsets><xref rid="f6-ceo-2016-00563" ref-type="fig"><offsets xml_i="15678" xml_f="15685" txt_i="9126" txt_f="9133">Figs. 6</offsets></xref><offsets xml_i="15692" xml_f="15694" txt_i="9133" txt_f="9135">, </offsets><xref rid="f7-ceo-2016-00563" ref-type="fig"><offsets xml_i="15739" xml_f="15740" txt_i="9135" txt_f="9136">7</offsets></xref><offsets xml_i="15747" xml_f="15749" txt_i="9136" txt_f="9138">).</offsets></p></sec><sec sec-type="discussion"><title><offsets xml_i="15793" xml_f="15803" txt_i="9140" txt_f="9150">DISCUSSION</offsets></title><p><offsets xml_i="15814" xml_f="16545" txt_i="9151" txt_f="9882">In this study, we compared the effects of four different spray combinations as premedication in nasal endoscopy. We confirmed that lidocaine spray is very uncomfortable for patients. Besides, it does not reduce pain during endoscopy, and it narrows the field of view in nasal passages and prolongs the duration of endoscopy. According to our results, oxymetazoline is comfortable for patients. It reduces pain during endoscopy and provides a wide field of view for the endoscopist. However, it causes a slight increase in arterial blood pressure. When oxymetazoline and lidocaine are used together, pain due to endoscopy is reduced significantly, the endoscopist’s field of view is wide, and the duration of endoscopy is shortened.</offsets></p><p><offsets xml_i="16552" xml_f="16720" txt_i="9883" txt_f="10051">Premedication in NE is typically applied with sprays or cotton pledgets. Although application of cotton pledgets is an effective method, it is irritating for patients [</offsets><xref rid="b17-ceo-2016-00563" ref-type="bibr"><offsets xml_i="16767" xml_f="16769" txt_i="10051" txt_f="10053">17</offsets></xref><offsets xml_i="16776" xml_f="16777" txt_i="10053" txt_f="10054">,</offsets><xref rid="b18-ceo-2016-00563" ref-type="bibr"><offsets xml_i="16824" xml_f="16826" txt_i="10054" txt_f="10056">18</offsets></xref><offsets xml_i="16833" xml_f="16927" txt_i="10056" txt_f="10150">]. Thus, sprays are used more often, and we preferred sprays to cotton pledgets in this study.</offsets></p><p><offsets xml_i="16934" xml_f="17158" txt_i="10151" txt_f="10375">It is well known that lidocaine sprays have bad taste and smell, and that they anesthetize not only the nose but also the palate, nasopharynx, and throat. These features make lidocaine sprays uncomfortable for the patients [</offsets><xref rid="b5-ceo-2016-00563" ref-type="bibr"><offsets xml_i="17204" xml_f="17205" txt_i="10375" txt_f="10376">5</offsets></xref><offsets xml_i="17212" xml_f="17213" txt_i="10376" txt_f="10377">,</offsets><xref rid="b6-ceo-2016-00563" ref-type="bibr"><offsets xml_i="17259" xml_f="17260" txt_i="10377" txt_f="10378">6</offsets></xref><offsets xml_i="17267" xml_f="17348" txt_i="10378" txt_f="10459">]. On the other hand, decongestant sprays do not have these unfavorable effects [</offsets><xref rid="b11-ceo-2016-00563" ref-type="bibr"><offsets xml_i="17395" xml_f="17397" txt_i="10459" txt_f="10461">11</offsets></xref><offsets xml_i="17404" xml_f="17516" txt_i="10461" txt_f="10573">]. Indeed, in this study, no differences were observed between oxymetazoline and placebo in terms of discomfort.</offsets></p><p><offsets xml_i="17523" xml_f="17620" txt_i="10574" txt_f="10671">Interestingly, even though lidocaine is an anesthetic, it does not reduce pain during endoscopy [</offsets><xref rid="b5-ceo-2016-00563" ref-type="bibr"><offsets xml_i="17666" xml_f="17667" txt_i="10671" txt_f="10672">5</offsets></xref><offsets xml_i="17674" xml_f="17675" txt_i="10672" txt_f="10673">,</offsets><xref rid="b11-ceo-2016-00563" ref-type="bibr"><offsets xml_i="17722" xml_f="17724" txt_i="10673" txt_f="10675">11</offsets></xref><offsets xml_i="17731" xml_f="17732" txt_i="10675" txt_f="10676">,</offsets><xref rid="b19-ceo-2016-00563" ref-type="bibr"><offsets xml_i="17779" xml_f="17781" txt_i="10676" txt_f="10678">19</offsets></xref><offsets xml_i="17788" xml_f="17789" txt_i="10678" txt_f="10679">,</offsets><xref rid="b20-ceo-2016-00563" ref-type="bibr"><offsets xml_i="17836" xml_f="17838" txt_i="10679" txt_f="10681">20</offsets></xref><offsets xml_i="17845" xml_f="18637" txt_i="10681" txt_f="11473">]. In this study, we showed that pain scores were similar between lidocaine and placebo. In our opinion, the most important reason of pain during endoscopy with lidocaine is the congestion of turbinates. We reached this opinion with the evaluation of the physician’s field of view. The field of view with lidocaine was narrower than with placebo. Moreover, while nasal decongestion was best achieved with oxymetazoline, the field of view decreased when oxymetazoline was used in combination with lidocaine. On the other hand, the best pain score was attained by lidocaine plus oxymetazoline. Therefore, the combined use of decongestant and lidocaine decreased pain compared to decongestant only. Therefore, the anesthetic effect of lidocaine could be obtained when turbinates are decongested.</offsets></p><p><offsets xml_i="18644" xml_f="18871" txt_i="11474" txt_f="11701">Some physicians avoid using premedication for NE because of its systemic effects. Even though clinicians suppose that topical decongestants cause hypertension and reflex bradycardia, there are not many studies supporting this [</offsets><xref rid="b7-ceo-2016-00563" ref-type="bibr"><offsets xml_i="18917" xml_f="18918" txt_i="11701" txt_f="11702">7</offsets></xref><offsets xml_i="18925" xml_f="19000" txt_i="11702" txt_f="11777">]. Similarly, NE may also increase pulse rate and arterial blood pressure [</offsets><xref rid="b4-ceo-2016-00563" ref-type="bibr"><offsets xml_i="19046" xml_f="19047" txt_i="11777" txt_f="11778">4</offsets></xref><offsets xml_i="19054" xml_f="20000" txt_i="11778" txt_f="12724">]. However, as clinicians, we use decongestant sprays and perform endoscopies relatively often, but do not observe these changes as often as supposed. In this study, we showed that oxymetazoline slightly increased MBP 10 minutes after its application, but MBP returned to its initial level immediately after endoscopy. Interestingly, this effect of oxymetazoline was not seen when it was combined with lidocaine. We also showed that the pulse rate did not change significantly with any of the sprays used in this study. Furthermore, the changes of pulse rate and blood pressure due to the sprays and endoscopy were not clinically relevant. However, this finding may be a result of the exclusion of elders and patients with cardiovascular diseases. Therefore, we recommend using decongestants carefully in elderly patients and in patients with cardiovascular diseases. Nonetheless, these sprays can be used safely in young and healthy individuals.</offsets></p><p><offsets xml_i="20007" xml_f="20696" txt_i="12725" txt_f="13414">The duration of endoscopic examination can also be an issue for physicians. In this regard, we evaluated the duration of endoscopy in order to consider the demands of physicians as well as of patients. This has not been considered in any of the similar studies so far. Our findings showed that the shortest duration of examination as well as the minimum pain score were provided by the decongestant–anesthetic combination. On the other hand, the best decongestion was obtained with decongestant alone. Standing on these observations, we suggest that duration of endoscopy is not only related to the wide passage in the nose but also strongly related to the patient’s feeling of nasal pain.</offsets></p><p><offsets xml_i="20703" xml_f="21174" txt_i="13415" txt_f="13886">In conclusion, the combined use of a decongestant and an anesthetic spray provided better field of view, reduced pain significantly, and decreased the duration of endoscopy. For these reasons, we considered decongestant plus anesthetic the best premedication method for nasal endoscopy. Because anesthetic sprays have bad taste and smell, we recommend using a decongestant spray alone in patients who refuse to use an anesthetic spray, while considering its side effects.</offsets></p></sec><sec><title><offsets xml_i="21196" xml_f="21206" txt_i="13888" txt_f="13898">HIGHLIGHTS</offsets></title><boxed-text position="float" orientation="portrait"><p><offsets xml_i="21269" xml_f="21325" txt_i="13899" txt_f="13955">▪ Lidocaine discomforted the patients more than placebo.</offsets></p><p><offsets xml_i="21332" xml_f="21414" txt_i="13956" txt_f="14038">▪ Oxymetazoline caused the best and lidocaine caused the worst decongestion score.</offsets></p><p><offsets xml_i="21421" xml_f="21512" txt_i="14039" txt_f="14130">▪ The lowest pain score related to endoscopy was obtained for oxymetazoline plus lidocaine.</offsets></p><p><offsets xml_i="21519" xml_f="21610" txt_i="14131" txt_f="14222">▪ Decongestant plus anesthetic spray seems to be the best premedication in nasal endoscopy.</offsets></p></boxed-text></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No potential conflict of interest relevant to this article was reported.</p></fn></fn-group><ack><p>We thank Gülhan Şimşek, the nurse of outpatient otolaryngology clinic of Erciyes University Medical School, for helping us collecting the data. This study was presented at International Otorhinolaryngology Head &amp; Neck Surgery Congress in Ankara, Turkey (April 17–19, 2014).</p></ack><ref-list><title>REFERENCES</title><ref id="b1-ceo-2016-00563"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaviola</surname><given-names>GC</given-names></name><name><surname>Chen</surname><given-names>V</given-names></name><name><surname>Chia</surname><given-names>SH</given-names></name></person-group><article-title>A prospective, randomized, double-blind study comparing the efficacy of topical anesthetics in nasal endoscopy</article-title><source>Laryngoscope</source><year>2013</year><month>4</month><volume>123</volume><issue>4</issue><fpage>852</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23404424</pub-id></element-citation></ref><ref id="b2-ceo-2016-00563"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Midwinter</surname><given-names>KI</given-names></name><name><surname>Ahmed</surname><given-names>A</given-names></name><name><surname>Willatt</surname><given-names>D</given-names></name></person-group><article-title>A randomised trial of flexible versus rigid nasendoscopy in outpatient sinonasal examination</article-title><source>Clin Otolaryngol Allied Sci</source><year>2001</year><month>8</month><volume>26</volume><issue>4</issue><fpage>281</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">11559337</pub-id></element-citation></ref><ref id="b3-ceo-2016-00563"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nankivell</surname><given-names>PC</given-names></name><name><surname>Pothier</surname><given-names>DD</given-names></name></person-group><article-title>Nasal and instrument preparation prior to rigid and flexible nasendoscopy: a systematic review</article-title><source>J Laryngol Otol</source><year>2008</year><month>10</month><volume>122</volume><issue>10</issue><fpage>1024</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18492307</pub-id></element-citation></ref><ref id="b4-ceo-2016-00563"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ongkasuwan</surname><given-names>J</given-names></name><name><surname>Yung</surname><given-names>KC</given-names></name><name><surname>Courey</surname><given-names>MS</given-names></name></person-group><article-title>The physiologic impact of transnasal flexible endoscopy</article-title><source>Laryngoscope</source><year>2012</year><month>6</month><volume>122</volume><issue>6</issue><fpage>1331</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">22499435</pub-id></element-citation></ref><ref id="b5-ceo-2016-00563"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frosh</surname><given-names>AC</given-names></name><name><surname>Jayaraj</surname><given-names>S</given-names></name><name><surname>Porter</surname><given-names>G</given-names></name><name><surname>Almeyda</surname><given-names>J</given-names></name></person-group><article-title>Is local anaesthesia actually beneficial in flexible fibreoptic nasendoscopy?</article-title><source>Clin Otolaryngol Allied Sci</source><year>1998</year><month>6</month><volume>23</volume><issue>3</issue><fpage>259</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">9669077</pub-id></element-citation></ref><ref id="b6-ceo-2016-00563"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>V</given-names></name><name><surname>Brockbank</surname><given-names>MJ</given-names></name><name><surname>Todd</surname><given-names>GB</given-names></name></person-group><article-title>Flexible transnasal endoscopy: is local anaesthetic necessary?</article-title><source>J Laryngol Otol</source><year>1997</year><month>7</month><volume>111</volume><issue>7</issue><fpage>616</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9282197</pub-id></element-citation></ref><ref id="b7-ceo-2016-00563"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latham</surname><given-names>GJ</given-names></name><name><surname>Jardine</surname><given-names>DS</given-names></name></person-group><article-title>Oxymetazoline and hypertensive crisis in a child: can we prevent it?</article-title><source>Paediatr Anaesth</source><year>2013</year><month>10</month><volume>23</volume><issue>10</issue><fpage>952</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">23679077</pub-id></element-citation></ref><ref id="b8-ceo-2016-00563"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cain</surname><given-names>AJ</given-names></name><name><surname>Murray</surname><given-names>DP</given-names></name><name><surname>McClymont</surname><given-names>LG</given-names></name></person-group><article-title>The use of topical nasal anaesthesia before flexible nasendoscopy: a double-blind, randomized controlled trial comparing cophenylcaine with placebo</article-title><source>Clin Otolaryngol Allied Sci</source><year>2002</year><month>12</month><volume>27</volume><issue>6</issue><fpage>485</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12472516</pub-id></element-citation></ref><ref id="b9-ceo-2016-00563"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Georgalas</surname><given-names>C</given-names></name><name><surname>Sandhu</surname><given-names>G</given-names></name><name><surname>Frosh</surname><given-names>A</given-names></name><name><surname>Xenellis</surname><given-names>J</given-names></name></person-group><article-title>Cophenylcaine spray vs. placebo in flexible nasendoscopy: a prospective double-blind randomised controlled trial</article-title><source>Int J Clin Pract</source><year>2005</year><month>2</month><volume>59</volume><issue>2</issue><fpage>130</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">15854186</pub-id></element-citation></ref><ref id="b10-ceo-2016-00563"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leder</surname><given-names>SB</given-names></name><name><surname>Ross</surname><given-names>DA</given-names></name><name><surname>Briskin</surname><given-names>KB</given-names></name><name><surname>Sasaki</surname><given-names>CT</given-names></name></person-group><article-title>A prospective, double-blind, randomized study on the use of a topical anesthetic, vasoconstrictor, and placebo during transnasal flexible fiberoptic endoscopy</article-title><source>J Speech Lang Hear Res</source><year>1997</year><month>12</month><volume>40</volume><issue>6</issue><fpage>1352</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9430755</pub-id></element-citation></ref><ref id="b11-ceo-2016-00563"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrestha</surname><given-names>BL</given-names></name><name><surname>Amatya</surname><given-names>RC</given-names></name></person-group><article-title>Local anesthesia versus placebo in flexible nasopharyngo-laryngoscopy</article-title><source>J Rhinol-Otol</source><year>2013</year><volume>1</volume><fpage>52</fpage><lpage>6</lpage></element-citation></ref><ref id="b12-ceo-2016-00563"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>R</given-names></name><name><surname>Hawke</surname><given-names>L</given-names></name><name><surname>Wormald</surname><given-names>PJ</given-names></name></person-group><article-title>Topical anaesthesia before nasendoscopy: a randomized controlled trial of co-phenylcaine compared with lignocaine</article-title><source>Clin Otolaryngol</source><year>2006</year><month>2</month><volume>31</volume><issue>1</issue><fpage>33</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16441799</pub-id></element-citation></ref><ref id="b13-ceo-2016-00563"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>PE</given-names></name><name><surname>Belafsky</surname><given-names>PC</given-names></name><name><surname>Postma</surname><given-names>GN</given-names></name></person-group><article-title>Topical nasal anesthesia for transnasal fiberoptic laryngoscopy: a prospective, double-blind, cross-over study</article-title><source>Otolaryngol Head Neck Surg</source><year>2003</year><month>4</month><volume>128</volume><issue>4</issue><fpage>452</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">12707645</pub-id></element-citation></ref><ref id="b14-ceo-2016-00563"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasemsuwan</surname><given-names>L</given-names></name><name><surname>Griffiths</surname><given-names>MV</given-names></name></person-group><article-title>Lignocaine with adrenaline: is it as effective as cocaine in rhinological practice?</article-title><source>Clin Otolaryngol Allied Sci</source><year>1996</year><month>4</month><volume>21</volume><issue>2</issue><fpage>127</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8735396</pub-id></element-citation></ref><ref id="b15-ceo-2016-00563"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Freitas</surname><given-names>RP</given-names></name><name><surname>Hannah</surname><given-names>BC</given-names></name></person-group><article-title>Re: nasal and instrument preparation prior to rigid and flexible nasendoscopy: a systematic review</article-title><source>J Laryngol Otol</source><year>2009</year><month>10</month><volume>123</volume><issue>10</issue><fpage>1188</fpage><pub-id pub-id-type="pmid">19457273</pub-id></element-citation></ref><ref id="b16-ceo-2016-00563"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunkaraneni</surname><given-names>VS</given-names></name><name><surname>Jones</surname><given-names>SE</given-names></name></person-group><article-title>Topical anaesthetic or vasoconstrictor preparations for flexible fibre-optic nasal pharyngoscopy and laryngoscopy</article-title><source>Cochrane Database Syst Rev</source><year>2011</year><month>3</month><issue>3</issue><fpage>CD005606</fpage><pub-id pub-id-type="pmid">21412890</pub-id></element-citation></ref><ref id="b17-ceo-2016-00563"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>CT</given-names></name></person-group><article-title>Gauze pledgetting versus endoscopic-guided aerosolized spray for nasal anesthesia before transnasal EGD: a prospective, randomized study</article-title><source>Gastrointest Endosc</source><year>2010</year><month>1</month><volume>71</volume><issue>1</issue><fpage>11</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">19748613</pub-id></element-citation></ref><ref id="b18-ceo-2016-00563"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>P</given-names></name><name><surname>Kaushik</surname><given-names>M</given-names></name><name><surname>Dehadaray</surname><given-names>A</given-names></name><name><surname>Qadri</surname><given-names>H</given-names></name><name><surname>Raichurkar</surname><given-names>A</given-names></name><name><surname>Seth</surname><given-names>T</given-names></name></person-group><article-title>Preparation of nose for nasal endoscopy: cotton pledget packing versus topical spray. A prospective randomized blinded study</article-title><source>Eur Arch Otorhinolaryngol</source><year>2013</year><month>1</month><volume>270</volume><issue>1</issue><fpage>117</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">22427029</pub-id></element-citation></ref><ref id="b19-ceo-2016-00563"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonaparte</surname><given-names>JP</given-names></name><name><surname>Javidnia</surname><given-names>H</given-names></name><name><surname>Kilty</surname><given-names>S</given-names></name></person-group><article-title>A double-blind randomised controlled trial assessing the efficacy of topical lidocaine in extended flexible endoscopic nasal examinations</article-title><source>Clin Otolaryngol</source><year>2011</year><month>12</month><volume>36</volume><issue>6</issue><fpage>550</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">22017968</pub-id></element-citation></ref><ref id="b20-ceo-2016-00563"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonas</surname><given-names>NE</given-names></name><name><surname>Visser</surname><given-names>MF</given-names></name><name><surname>Oomen</surname><given-names>A</given-names></name><name><surname>Albertyn</surname><given-names>R</given-names></name><name><surname>van Dijk</surname><given-names>M</given-names></name><name><surname>Prescott</surname><given-names>CA</given-names></name></person-group><article-title>Is topical local anaesthesia necessary when performing paediatric flexible nasendoscopy? A double-blind randomized controlled trial</article-title><source>Int J Pediatr Otorhinolaryngol</source><year>2007</year><month>11</month><volume>71</volume><issue>11</issue><fpage>1687</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">17720256</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-ceo-2016-00563" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>Flowchart of the method. NS, normal saline; Decong., decongestant; Anest., anesthetic; VAS, visual analog scale.</p></caption><graphic xlink:href="ceo-2016-00563f1"></graphic></fig><fig id="f2-ceo-2016-00563" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p>Visual analog scale (VAS) questionnaires.</p></caption><graphic xlink:href="ceo-2016-00563f2"></graphic></fig><fig id="f3-ceo-2016-00563" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p>Distribution of visual analog scale (VAS) scores of discomfort due to the spray. Numbers in brackets show the type of the spray combination. [1] placebo; [2] decongestant; [3] anesthetic; [4] decongestant plus anesthetic. Numbers before the names of the sprays show the order in that combination. NS, normal saline.</p></caption><graphic xlink:href="ceo-2016-00563f3"></graphic></fig><fig id="f4-ceo-2016-00563" orientation="portrait" position="float"><label>Fig. 4.</label><caption><p>Distribution of visual analog scale (VAS) scores of nasal pain and decongestion. Numbers in brackets show the type of the spray combination. [1] placebo (NS+NS); [2] decongestant (NS+oxymeta-zoline); [3] anesthetic (NS+lidocaine); [4] decongestant plus anesthetic (oxymetazoline+lidocaine). NS, normal saline.</p></caption><graphic xlink:href="ceo-2016-00563f4"></graphic></fig><fig id="f5-ceo-2016-00563" orientation="portrait" position="float"><label>Fig. 5.</label><caption><p>Distribution of durations of the endoscopic examinations. NS, normal saline.</p></caption><graphic xlink:href="ceo-2016-00563f5"></graphic></fig><fig id="f6-ceo-2016-00563" orientation="portrait" position="float"><label>Fig. 6.</label><caption><p>Distribution of changes of the mean blood pressure from the beginning to 10 minutes after spray application and from that point to just after endoscopy. NS, normal saline.</p></caption><graphic xlink:href="ceo-2016-00563f6"></graphic></fig><fig id="f7-ceo-2016-00563" orientation="portrait" position="float"><label>Fig. 7.</label><caption><p>Distribution of changes of the pulse rate from the beginning to 10 minutes after spray application and from that point to just after endoscopy. NS, normal saline; BPM, beats per minute.</p></caption><graphic xlink:href="ceo-2016-00563f7"></graphic></fig></floats-group></article>